 |
BRAZIL: A Bold Player Blooms
Everything you need to know to do business in the country
Key economic sector data, exclusive interviews from regional leaders, and a company directory
From Focus Reports, Ltd., Pharmaceutical Executive and Pharmaceutical Executive Global Digest
|
 |
Brazil
was the last country to enter the financial crisis, and the first to
exit. The country is emerging from a decade which saw 40 million of its
200 million inhabitants joining the middle class, and creating a new
block of "pharmerging" consumers. This bulging middle class has been the
main driver in Brazil's retail pharmaceutical market, more than
doubling to $26 billion (U.S.) and projected to reach top 5 by 2015.
Written
after exclusive interviews with Brazil's decision makers from local and
multinational companies, manufacturers, distributors, experts,
legislators, this is a unique resource for those looking beyond figures.
Contributors
include: ANVISA, SINDUSPHARMA, Sanofi, Pfizer, Roche, Novartis,
Boehringer Ingelheim, Eli Lilly, Ferring Astellas, Ipsen, and many more. PDF Report: $129.99
|
|
Focus
Reports serves business professionals in the Pharmaceutical industry.
The country reports offer a snapshot of the challenges and
issues faced by an
industry through the voice and insight of the decision makers
at governmental, legislative and corporate levels. They are based on
exclusive interviews
conducted by our staff. |
 |
| |
|